Krystal Biotech, Inc. Stock-Based Compensation
Krystal Biotech, Inc. (KRYS) reported Stock-Based Compensation of $27.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-03
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $14.16M, a 0.26% increase year-over-year.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $13.61M, a 0.97% increase year-over-year.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $13.76M, a 3.05% increase year-over-year.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $13.15M, a 1.22% decline year-over-year.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $54.51M, a 10.97% increase from fiscal 2024.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $49.13M, a 23.02% increase from fiscal 2023.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $39.93M, a 20.17% increase from fiscal 2022.
- Krystal Biotech, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $33.23M, a 116.92% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $27.77M 10-Q · filed 2026-08-03 | $41.53M derived: sum of 3 quarters · filed 2026-08-03 | $54.68M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $13.61M 10-Q · filed 2026-05-04 | $27.37M derived: sum of 2 quarters · filed 2026-05-04 | $40.53M derived: sum of 3 quarters · filed 2026-05-04 | $54.65M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $13.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $26.92M derived: sum of 2 quarters · filed 2026-02-17 | $41.04M derived: sum of 3 quarters · filed 2026-08-03 | $54.51M 10-K · filed 2026-02-17 |
| 2025-09-30 | $13.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $27.27M derived: sum of 2 quarters · filed 2026-08-03 | $40.75M 10-Q · filed 2025-11-03 | $54.11M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $14.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $27.60M 10-Q · filed 2026-08-03 | $40.95M derived: sum of 3 quarters · filed 2026-08-03 | $54.27M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $13.48M 10-Q · filed 2026-05-04 | $26.83M derived: sum of 2 quarters · filed 2026-05-04 | $40.15M derived: sum of 3 quarters · filed 2026-05-04 | $53.31M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $26.67M derived: sum of 2 quarters · filed 2026-02-17 | $39.83M derived: sum of 3 quarters · filed 2026-02-17 | $49.13M 10-K · filed 2026-02-17 |
| 2024-09-30 | $13.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $26.47M derived: sum of 2 quarters · filed 2025-11-03 | $35.77M 10-Q · filed 2025-11-03 | $45.62M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $13.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $22.45M 10-Q · filed 2025-08-04 | $32.31M derived: sum of 3 quarters · filed 2026-02-17 | $40.62M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $9.30M 10-Q · filed 2025-05-06 | $19.15M derived: sum of 2 quarters · filed 2026-02-17 | $27.46M derived: sum of 3 quarters · filed 2026-02-17 | $38.80M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $9.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $18.16M derived: sum of 2 quarters · filed 2026-02-17 | $29.50M derived: sum of 3 quarters · filed 2026-02-17 | $39.93M 10-K · filed 2026-02-17 |
| 2023-09-30 | $8.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $19.64M derived: sum of 2 quarters · filed 2024-11-04 | $30.08M 10-Q · filed 2024-11-04 | $39.63M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $11.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $21.77M 10-Q · filed 2024-08-05 | $31.32M derived: sum of 3 quarters · filed 2025-02-19 | $40.38M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $10.44M 10-Q · filed 2024-05-06 | $19.99M derived: sum of 2 quarters · filed 2025-02-19 | $29.05M derived: sum of 3 quarters · filed 2025-02-19 | $37.24M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $9.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $18.61M derived: sum of 2 quarters · filed 2025-02-19 | $26.80M derived: sum of 3 quarters · filed 2025-02-19 | $33.23M 10-K · filed 2025-02-19 |
| 2022-09-30 | $9.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $17.25M derived: sum of 2 quarters · filed 2023-11-06 | $23.68M 10-Q · filed 2023-11-06 | $28.82M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $14.62M 10-Q · filed 2023-08-07 | $19.76M derived: sum of 3 quarters · filed 2024-02-26 | $23.43M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $6.43M 10-Q · filed 2023-05-08 | $11.57M derived: sum of 2 quarters · filed 2024-02-26 | $15.24M derived: sum of 3 quarters · filed 2024-02-26 | $19.44M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $8.81M derived: sum of 2 quarters · filed 2024-02-26 | $13.01M derived: sum of 3 quarters · filed 2024-02-26 | $15.32M 10-K · filed 2024-02-26 |
| 2021-09-30 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $7.86M derived: sum of 2 quarters · filed 2022-11-07 | $10.17M 10-Q · filed 2022-11-07 | $10.74M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $6.51M 10-Q · filed 2022-08-08 | $7.08M derived: sum of 3 quarters · filed 2023-02-27 | $8.43M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $2.31M 10-Q · filed 2022-05-09 | $2.88M derived: sum of 2 quarters · filed 2023-02-27 | $4.24M derived: sum of 3 quarters · filed 2023-02-27 | $5.05M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.93M derived: sum of 2 quarters · filed 2023-02-27 | $2.73M derived: sum of 3 quarters · filed 2023-02-27 | $3.27M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $2.16M derived: sum of 2 quarters · filed 2021-11-08 | $2.70M 10-Q · filed 2021-11-08 | $3.02M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $807.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.35M 10-Q · filed 2021-08-09 | $1.67M derived: sum of 3 quarters · filed 2021-08-09 | $1.95M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $539.00K 10-Q · filed 2021-05-10 | $862.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.14M derived: sum of 3 quarters · filed 2021-05-10 | $1.47M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $601.00K derived: sum of 2 quarters · filed 2021-03-01 | $926.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.24M 10-K · filed 2021-03-01 |
| 2019-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $603.00K derived: sum of 2 quarters · filed 2020-11-09 | $916.00K 10-Q · filed 2020-11-09 | $1.22M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $325.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $638.00K 10-Q · filed 2020-08-07 | $940.00K derived: sum of 3 quarters · filed 2020-08-07 | $1.22M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $313.00K 10-Q · filed 2020-05-04 | $615.00K derived: sum of 2 quarters · filed 2020-05-04 | $893.00K derived: sum of 3 quarters · filed 2020-05-04 | $1.04M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $580.00K derived: sum of 2 quarters · filed 2020-03-10 | $727.00K derived: sum of 3 quarters · filed 2020-03-10 | $792.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $425.00K derived: sum of 2 quarters · filed 2019-11-04 | $490.00K 10-Q · filed 2019-11-04 | $548.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $212.00K 10-Q · filed 2019-08-05 | $270.00K derived: sum of 3 quarters · filed 2019-08-05 | $323.00K derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $65.00K 10-Q · filed 2019-05-07 | $123.00K derived: sum of 2 quarters · filed 2019-05-07 | $176.00K derived: sum of 3 quarters · filed 2019-05-07 | $220.00K derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $111.00K derived: sum of 2 quarters · filed 2018-11-05 | $155.00K derived: sum of 3 quarters · filed 2018-11-05 | $246.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $97.00K derived: sum of 2 quarters · filed 2018-11-05 | $188.00K 10-Q · filed 2018-11-05 | $214.00K derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $135.00K 10-Q · filed 2018-08-06 | $161.00K derived: sum of 3 quarters · filed 2018-08-06 | |
| 2017-03-31 | $91.00K 10-Q · filed 2018-05-07 | $117.00K derived: sum of 2 quarters · filed 2018-05-07 | ||
| 2016-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $33.00K 10-K · filed 2018-03-12 | ||
| 2016-09-30 | $7.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |